Promise vs. Realities in AI: Building Trust Brick by Brick

#networking
Share

Join a professional audience sharing an important conversation on AI's impact in 2026.


AI's evolving tools and impacts on healthcare and job search, including reliability, safety, trust and what's next.  For a solid review of AI’s advances and the issues these are surfacing, do join us.

Featured presenters: Laura Truncellito (CEO-Employable.AI); Lee Dudka, Board Director, Throne Biotech.

PLEASE NOTE: We’re offering limited attendance, allowing more effective  networking.  PLEASE REGISTER QUICKLY IF INTERESTED.

 

Parking and directions: Park in garage across the street from the Tower Building and bring parking ticket with you to the event. In the Tower Building, take the lobby elevator to the 14th floor, then switch elevators to get to the 17th floor.



  Date and Time

  Location

  Hosts

  Registration



  • Add_To_Calendar_icon Add Event to Calendar
  • Tower Club
  • 8000 Towers Crescent
  • Vienna, Virginia
  • United States 22182
  • Room Number: Skyline Room, 17th Floor

  • Contact Event Host
  • Starts 15 January 2026 05:00 AM UTC
  • Ends 20 January 2026 05:00 AM UTC
  • No Admission Charge


  Speakers

Laura Truncellito of Employable.AI

Topic:

Value-based AI job matching

CEO-Employable.AI

Biography:

Laura Truncellito, a machine learning engineer and entrepreneur, is CEO and CTO of Enployable, Inc, the world’s first value-based AI job matching platform. Enployable AI is led by machine learning engineers, data scientists and HR specialists from MIT and Stanford with extensive experience in AI. It has been recognized by Nasdaq, WeWork, Founder Institute, the National Science Foundation, and was the 2021 HackerNoon Startup of the Year in Virginia. In 2025, Enployable AI was selected for Nvidia Inception as one of the world’s most promising startups, and was named a Tech 100 honoree by Northern Virginia Technology Council.

Laura has founded two companies and contributed to discussions on technology's future for the MIT Technology Review Global Panel.

She holds a Master’s in Technology Entrepreneurship from the University of Maryland and has earned certifications in AI Product Design, Applied Data Science, and AI and Business Strategy from MIT’s Sloan School of Management and Computer Science & Artificial Intelligence Laboratory. Laura has received scholarships from Google, Facebook, Intel, Nutanix, and Microsoft Azure. She is a proud alumna of Nasdaq Milestone Circles.

Laura is a member of the National Small Business Association Leadership Council, serving on the committees for Technology, Health and Human Resources, and Environment and Regulatory Affairs. She was a 2024 Small Business Advocate of the Year Award finalist. Laura serves on the NVTC AI and Digital Transformation Committee’s Leadership Board. In 2023, she was an invited member of Senate Majority Leader Chuck Schumer's AI Policy Roundtable.

Lee Dudka of Throne Biotech

Topic:

AI's impact on health care

Biography:

As Board Director (Throne Biotech) and CEO-team Adviser, Lee Dudka serves premier US and global companies with analytics-driven strategies that tap core emerging AI technology. His extensive biopharma work (Bristol-Myers Squibb, J&J, Pfizer, GSK) includes key telecom/tech groups (Marriott, Honeywell, CACI) and hospitals.  He empowers executive teams reacting to today’s fast-changing and operational demands.

European-born and raised in Brazil, he completed degrees at Rutgers and Princeton (Co-Directing the Princeton Writing Workshop) plus taught at Princeton, Rutgers and SUNY-Purchase.

Alongside board work, he’s led strategy and reengineering on Fortune 200 projects (new drug development, enhanced workflows, data network upgrades).  His operations experience reflects a background in electrical engineering, NIH and FDA research and psychotherapy (Rutgers Medical School). He’s chaired key committees at the Princeton University Alumni Council and fundraises to support Ukraine’s medical needs on its frontlines.






Agenda

6:00 pm  Welcome and introductions

6:00 - 7:00 pm   Two-part panel discussion with Q&A

7:00 - 8:00 pm   Networking and discussion opportunity, with light refreshments